Navigating UK–EU divergence on gene-edited food labelling

Under the Precision Breeding Act, products developed through precision breeding won't require the GMO label that would apply under the old EU-derived rules — they're treated more like conventionally bred crops. But the FSA still needs to authorise each precision-bred organism before it enters the food chain. That authorisation process is still being set up; the first applications are only expected in late 2025. For your suppliers, the question is whether their ingredients will have FSA sign-off before they want to switch.

Yes — the EU is reviewing its NGT (New Genomic Techniques) regulation but it's not finalised. As it stands, anything classified as precision-bred under UK law would likely still require full GMO authorisation for EU sale. That means you could end up needing two separate supply chains or formulations if you're selling in both markets. The EU NGT regulation is worth watching closely — if it passes in a form that aligns with UK definitions, the problem largely goes away.